12.05.2020 • News

Inovyn Participates in Sustainable Methanol Project

Inovyn Participates in Sustainable Methanol Project
Inovyn Participates in Sustainable Methanol Project

Vinyls producer Inovyn, wholly owned by Ineos, is taking part in a project to produce sustainable methanol in Antwerp, Belgium.

The company is one of seven other firms investigating options in the ‘Power to Methanol’ project, which aims to produce methanol from captured CO2 combined with hydrogen generated from renewable electricity. Methanol is currently produced from fossil-based raw materials, which emit CO2 from the process.

Subject to the successful outcome of the study, an 8,000 t/y industrial-scale demonstration plant will be built at Inovyn’s site in Lillo. The facility, said Inovyn, would be the first of its kind for Belgium, with the methanol output being used by chemical companies in the port of Antwerp cluster. It would save at least 8,000 t/y of CO2 emissions, the company added.

“This is a very exciting project and an excellent fit with our sustainability strategy, which includes pursuing options for alternative energy and the sustainable, lower carbon production of chemicals,” said Inovyn CEO Geir Tuft, adding that the company will be contributing its expertise in hydrogen production and electrolysis to the project.

The other consortium members are Engie, Oiltanking, Indaver, Fluxys, the Flemish Environmental Holding Company (Vlaamse Milieu Holding) and Port of Antwerp.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read